Core Laboratories (NYSE:CLB) Price Target Raised to $15.00

Core Laboratories (NYSE:CLB - Get Free Report) had its target price lifted by Citigroup from $14.00 to $15.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a "sell" rating on the oil and gas company's stock. Citigroup's price target suggests a potential downside of 6.98% from the stock's current price.

Separately, StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to data from MarketBeat.com, Core Laboratories presently has an average rating of "Hold" and an average target price of $17.25.

Core Laboratories Stock Down 4.4 %

Shares of CLB stock traded down $0.75 during trading on Thursday, hitting $16.13. 314,757 shares of the company were exchanged, compared to its average volume of 310,331. Core Laboratories has a twelve month low of $13.82 and a twelve month high of $25.13. The business's 50-day simple moving average is $17.96 and its 200 day simple moving average is $18.80. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. The firm has a market capitalization of $755.13 million, a price-to-earnings ratio of 24.43, a P/E/G ratio of 0.99 and a beta of 2.38.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. As a group, analysts forecast that Core Laboratories will post 0.96 EPS for the current fiscal year.

Institutional Investors Weigh In On Core Laboratories

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mackenzie Financial Corp acquired a new stake in Core Laboratories in the 4th quarter worth approximately $405,000. Squarepoint Ops LLC lifted its holdings in Core Laboratories by 91.5% in the 4th quarter. Squarepoint Ops LLC now owns 111,305 shares of the oil and gas company's stock worth $1,927,000 after purchasing an additional 53,188 shares during the last quarter. Two Sigma Investments LP lifted its holdings in Core Laboratories by 11.9% in the 4th quarter. Two Sigma Investments LP now owns 84,277 shares of the oil and gas company's stock worth $1,459,000 after purchasing an additional 8,957 shares during the last quarter. Tidal Investments LLC lifted its holdings in Core Laboratories by 13.1% in the 4th quarter. Tidal Investments LLC now owns 49,587 shares of the oil and gas company's stock worth $858,000 after purchasing an additional 5,725 shares during the last quarter. Finally, Sherbrooke Park Advisers LLC acquired a new stake in Core Laboratories in the 4th quarter worth approximately $176,000. 97.81% of the stock is currently owned by institutional investors and hedge funds.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.